Fenofibrate therapy may significantly lower bilirubin levels in full-term infants with newborn jaundice who have levels below ...

A cohort study of 20 pregnancies complicated by HDFN highlights the correlation between early diagnosis and favorable ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...

Close medical vigilance is necessary to optimize outcomes in pregnancies at risk of early-onset HDFN. Pregnancies previously affected by early-onset hemolytic disease of the fetus and newborn (HDFN) ...

A novel clinical pathway was implemented at a large maternity care center to improve compliance with American Academy of Pediatrics (AAP) guidelines on timely evaluation of newborns at risk for ...

BEERSE, BELGIUM , April 08, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company, today announced results from additional analyses of the Phase 3 Vivacity-MG3 ...

The EMA and U.S. FDA have granted several key designations to nipocalimab including: EU EMA Orphan medicinal product designation for haemolytic disease of the foetus and newborn (HDFN) in October 2019 ...